The health and medical industry encompasses a wide range of fields, including pharmaceuticals, biotechnology, medical devices, and healthcare services. These sectors are heavily involved in R&D, making them prime candidates for various tax incentives and grant programs, particularly those aimed at innovation and patient care improvement.
Key Tax Credits and Incentives:
This credit is vital for pharmaceutical companies developing treatments for rare diseases. By offering a credit of up to 25% of qualified clinical testing expenses, the ODTC reduces the financial burden on companies investing in drugs that may have limited market potential due to their niche focus. This incentive often covers a large portion of development costs, thus encouraging innovation in areas that would otherwise be neglected.
Health and medical companies that engage in developing new drugs, medical devices, or innovative treatment methods can claim this credit. Eligible R&D activities include clinical trials, new product development, and process improvements. The ability to claim up to 20% of qualifying research expenses helps lower development costs, allowing firms to reinvest in further research.
Hospitals, clinics, and research laboratories often have highly specialized buildings and equipment. Cost segregation studies allow these companies to accelerate the depreciation of assets such as MRI machines, lab equipment, and energy-efficient improvements, resulting in substantial tax savings in the early years of operation. This boosts cash flow, which is crucial for funding new medical research and facility upgrades.
Relevant Grants and Funding Programs
NIH (National Institutes of Health) Funding
Many companies in this sector rely on federal grants, such as those provided by NIH, to fund clinical trials, drug discovery, and medical device development. NIH grants provide crucial support for early-stage research that is often too risky for private investment.
SBIR/STTR Programs
Small businesses in the health and medical sector can apply for Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) programs, which offer federal grants for early-stage R&D projects. These grants are especially helpful for startups working on breakthrough technologies in biotechnology or medical devices.
Healthcare Facilities
179D Commercial Building Deduction
Healthcare facilities can benefit from the 79D deduction by investing in energy-efficient designs. Hospitals and medical centers are known for their high energy consumption, so this incentive helps offset the cost of installing energy-saving HVAC systems, lighting, and equipment.
45L Tax Credit
This credit, typically used in residential construction, can be relevant for assisted living facilities or other housing projects related to healthcare. By implementing energy-efficient designs, developers can earn a $2,000 tax credit per qualifying unit.
Practical Application
and Compliance
Medical companies often face rigorous regulatory standards, making accurate documentation crucial for tax credits and grants. For example, when applying for the R&D Tax Credit, the company must provide thorough documentation of their research activities, including experiment designs, progress reports, and expenditures on R&D personnel.
When claiming the Orphan Drug Tax Credit, companies must track their clinical trial expenses meticulously to ensure they meet the eligibility criteria set by the FDA. Compliance with these tax credit requirements not only reduces the risk of audits but also maximizes the financial benefits for the company.
Your Benefits
Greater chances of success
With the help of our experience, you have a better chance of successful acceptances.
Performance-based remuneration
You pay largely based on success.
You can find out more about this in a personal meeting.
Significant time savings
With us, you save between 80 and 90% of your time and gain a clear roadmap for all decisions and future processes.
Accurate selection of the right programs
The area of subsidies is a broad field. We navigate you unerringly through the various funding programs.
Legal certainty
We advise you on financial planning before and after funding approval. This gives you legal certainty in the sometimes complex issues of finances and allocations.
Our Team of Consultants
Marius Ehrlinger
CEO/Founder
Julien André
Head of finance/CFO
M. A. Felix Clausberg
Senior Consultant Subsidies
Luca Prieß
Consultant Subsidies
Who Can Benefit from the Orphan Drug Tax Credit?
Large pharmaceutical companies can leverage the ODTC to reduce the financial risks associated with orphan drug development. This credit supports the continued investment in research that addresses unmet needs in the treatment of rare diseases.
For biotech startups focused on developing innovative therapies, the ODTC can be a critical source of financial support. This credit allows smaller companies to compete in the challenging field of rare disease treatment, fostering innovation and growth.
Academic institutions involved in drug development for rare diseases can also benefit from the ODTC. By partnering with commercial entities or pursuing their own projects, these institutions can access essential funding to advance their research.
Non-profits dedicated to finding treatments for rare diseases can utilize the ODTC when engaged in clinical testing. This credit can help stretch limited resources further, enabling more research and development efforts aimed at curing or managing rare conditions.
We'll help you secure
the grants you need
Complexity needs a trusted guide. With our expertise and cross-sector versatility we can deliver success. We work with organizations across many industries and pioneer new directions for the future.